See more : The Very Good Food Company Inc. (VERY.V) Income Statement Analysis – Financial Results
Complete financial analysis of Danimer Scientific, Inc. (DNMR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Danimer Scientific, Inc., a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
You may be interested
- Vente-Unique.com SA (ALVU.PA) Income Statement Analysis – Financial Results
- MS Young Adventure Enterprise, Inc. (MSYN) Income Statement Analysis – Financial Results
- 1Spatial Plc (SPA.L) Income Statement Analysis – Financial Results
- Jin Tong Ling Technology Group Co., Ltd. (300091.SZ) Income Statement Analysis – Financial Results
- Dufry AG (DUFRY) Income Statement Analysis – Financial Results
Danimer Scientific, Inc. (DNMR)
About Danimer Scientific, Inc.
Danimer Scientific, Inc., a performance polymer company, develops, produces, and provides bioplastic replacements for traditional petroleum-based plastics. It produces polyhydroxyalkanoate, a biodegradable plastic feedstock alternative used in a range of plastic applications, including films, straws, food containers, and other things under the Nodax brand name; polylactic acid-based resins for coating disposable paper cups; and other biopolymers. The company offers its products for biopolymers, including additives, aqueous coatings, fibers, filaments, films, thermoforming, and injection-molded articles. It also markets its products to consumer packaging brand owners, converters, and manufacturers in the plastics industry. Danimer Scientific, Inc. was founded in 2004 and is headquartered in Bainbridge, Georgia.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 46.68M | 53.22M | 58.75M | 47.33M | 32.34M | 30.45M |
| Cost of Revenue | 73.64M | 63.63M | 57.87M | 35.88M | 21.24M | 19.21M |
| Gross Profit | -26.96M | -10.41M | 884.00K | 11.46M | 11.11M | 11.25M |
| Gross Profit Ratio | -57.75% | -19.57% | 1.50% | 24.21% | 34.34% | 36.92% |
| Research & Development | 29.24M | 31.94M | 20.27M | 7.85M | 5.48M | 5.14M |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7.26M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 100.00K |
| SG&A | 68.98M | 81.59M | 80.00M | 19.34M | 16.03M | 7.36M |
| Other Expenses | 434.00K | 723.00K | -44.00K | -31.00K | 277.00K | 0.00 |
| Operating Expenses | 98.66M | 113.53M | 100.27M | 27.19M | 21.51M | 8.11M |
| Cost & Expenses | 172.30M | 177.16M | 158.14M | 63.07M | 42.75M | 27.32M |
| Interest Income | 0.00 | 1.72M | 763.00K | 347.00K | 340.00K | 2.88M |
| Interest Expense | 0.00 | 112.25M | 763.00K | 2.43M | 3.48M | 0.00 |
| Depreciation & Amortization | 29.06M | 20.09M | 11.67M | 4.61M | 3.51M | 3.54M |
| EBITDA | -96.46M | -103.49M | -87.72M | -10.30M | -6.90M | 2.35M |
| EBITDA Ratio | -206.61% | -90.63% | -151.15% | -21.76% | -12.87% | 7.70% |
| Operating Income | -125.62M | -187.43M | -99.39M | -15.74M | -10.40M | -1.19M |
| Operating Income Ratio | -269.08% | -352.20% | -169.18% | -33.25% | -32.16% | -3.91% |
| Total Other Income/Expenses | -29.54M | 6.87M | 26.13M | 6.88M | -5.03M | -2.91M |
| Income Before Tax | -155.15M | -180.57M | -73.34M | -12.57M | -15.43M | 259.00K |
| Income Before Tax Ratio | -332.35% | -339.30% | -124.84% | -26.56% | -47.70% | 0.85% |
| Income Tax Expense | 319.00K | -810.00K | -13.23M | 2.40M | 4.09M | 51.00K |
| Net Income | -155.47M | -179.76M | -60.11M | -14.97M | -19.51M | 208.00K |
| Net Income Ratio | -333.03% | -337.78% | -102.31% | -31.62% | -60.33% | 0.68% |
| EPS | -1.52 | -1.78 | -0.65 | -0.18 | -0.77 | 0.07 |
| EPS Diluted | -1.52 | -1.78 | -0.65 | -0.18 | -0.77 | 0.07 |
| Weighted Avg Shares Out | 102.00M | 101.10M | 93.08M | 84.54M | 25.37M | 2.97M |
| Weighted Avg Shares Out (Dil) | 102.00M | 101.10M | 93.08M | 84.54M | 25.37M | 2.96M |
TerraNova Capital Equities announces three transactions totaling $45 Million
NEW YORK , Nov. 20, 2024 /PRNewswire/ -- TerraNova Capital Equities, inc. (TerraNova), a leading financial advisory firm, is pleased to announce that its Structure Finance Group acted as sole advisor on three recent transactions: TerraNova Structured Finance Group acted...
Danimer Scientific, Inc. (DNMR) Q3 2024 Earnings Call Transcript
Danimer Scientific, Inc. (NYSE:DNMR ) Q3 2024 Earnings Conference Call November 19, 2024 10:00 AM ET Company Participants Rich Altice - Interim CEO Mike Hajost - CFO Conference Call Participants Unidentified Company Representative Thank you, operator. Good morning, everyone, and...
Danimer Scientific, Inc. (DNMR) Reports Q3 Loss, Tops Revenue Estimates
Danimer Scientific, Inc. (DNMR) came out with a quarterly loss of $0.24 per share versus the Zacks Consensus Estimate of a loss of $8. This compares to loss of $15.60 per share a year ago.
Danimer Scientific Announces Third Quarter 2024 Results
BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading next generation bioplastics company focused on the development and production of biodegradable materials, announced today financial results for its third quarter ended September 30, 2024. Richard N....
Danimer Scientific Announces Release Date for Third Quarter 2024 Results
BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading, next-generation bioplastics company focused on the development and production of biodegradable materials, announced today that the Company will release its third quarter 2024 financial results before the...
Danimer Scientific Announces Intention to Complete a Reverse Stock Split
BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or “Company”), a leading, next-generation biotechnology company focused on the production of biomaterials, announced today that, following approval by the Company's stockholders and its Board of Directors, the Company will effect a...
Danimer Scientific Announces Second Circuit Court Affirms Dismissal of Class Action Lawsuit
BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (“Company” or “Danimer Scientific”), a leading next generation bioplastics company focused on the development and production of biodegradable materials, announced that, on September 27, 2024, the United States Court of Appeals for the...
Ningbo Homelink Eco-iTech and Danimer Scientific Announce Commercial Launch of Home Compostable Extrusion Coating Biopolymer Based on PHA
BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer”), a leading, next-generation biotechnology company focused on the production of biodegradable materials, and Ningbo Homelink Eco-iTech Co. Ltd. (“Homelink”), a leading manufacturer of disposable tableware, have announced commercial launch of home compostable...
DoD Makes Award to Danimer Scientific via the Distributed Bioindustrial Manufacturing Program
BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer”), a leading, next-generation biotechnology company focused on the production of biomaterials, announces an award from the U.S. Department of Defense via the Distributed Bioindustrial Manufacturing Program (DBIMP). Danimer Scientific has been awarded...
What Makes Danimer Scientific (DNMR) a New Buy Stock
Danimer Scientific (DNMR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Source: https://incomestatements.info
Category: Stock Reports